We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+13.08%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$236M
AUM Growth
+$28.1M
Cap. Flow
+$4.13M
Cap. Flow %
1.75%
Top 10 Hldgs %
31.79%
Holding
548
New
49
Increased
102
Reduced
91
Closed
33

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$4.41M
2
XPO icon
XPO
XPO
+$4.19M
3
VTRS icon
Viatris
VTRS
+$3.33M
4
KLAC icon
KLA
KLAC
+$3.24M
5
TMUS icon
T-Mobile US
TMUS
+$3.18M

Sector Composition

Rank Sector Weight
1 Miscellaneous 39.12%
2 Technology 12.92%
3 Financials 9.11%
4 Healthcare 8.17%
5 Consumer Discretionary 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOG icon
401
Harley-Davidson
HOG
$2.87B
$5K ﹤0.01%
150
HPQ icon
402
HP
HPQ
$30.5B
$5K ﹤0.01%
253
IEUS icon
403
iShares MSCI Europe Small-Cap ETF
IEUS
$175M
$5K ﹤0.01%
104
JAZZ icon
404
Jazz Pharmaceuticals
JAZZ
$15.6B
$5K ﹤0.01%
34
KRE icon
405
State Street SPDR S&P Regional Banking ETF
KRE
$4.31B
$5K ﹤0.01%
103
LIN icon
406
Linde
LIN
$213B
$5K ﹤0.01%
29
TKC icon
407
Turkcell
TKC
$4.52B
$5K ﹤0.01%
1,000
VVV icon
408
Valvoline
VVV
$3.61B
$5K ﹤0.01%
291
CLVS
409
DELISTED
Clovis Oncology, Inc.
CLVS
$5K ﹤0.01%
195
AMLP icon
410
Alerian MLP ETF
AMLP
$13.4B
$4K ﹤0.01%
82
+1
+1% +$49
CALM icon
411
Cal-Maine
CALM
$3.47B
$4K ﹤0.01%
100
CTMX icon
412
CytomX Therapeutics
CTMX
$586M
$4K ﹤0.01%
362
EDIT icon
413
Editas Medicine
EDIT
$404M
$4K ﹤0.01%
154
GLP icon
414
Global Partners
GLP
$1.72B
$4K ﹤0.01%
200
HAP icon
415
VanEck Natural Resources ETF
HAP
$339M
$4K ﹤0.01%
114
HISF icon
416
First Trust Exchange-Traded Fund IV First Trust High Income Strategic Focus ETF
HISF
$99.3M
$4K ﹤0.01%
75
HPE icon
417
Hewlett Packard
HPE
$74.2B
$4K ﹤0.01%
253
LEMB icon
418
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$743M
$4K ﹤0.01%
100
MDIV icon
419
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
$425M
$4K ﹤0.01%
200
PGF icon
420
Invesco Financial Preferred ETF
PGF
$637M
$4K ﹤0.01%
200
SQM icon
421
Sociedad Química y Minera de Chile
SQM
$19.8B
$4K ﹤0.01%
106
TEF
422
DELISTED
Telefonica
TEF
$4K ﹤0.01%
554
TGT icon
423
Target
TGT
$70.1B
$4K ﹤0.01%
44
VDE icon
424
Vanguard Energy ETF
VDE
$11.2B
$4K ﹤0.01%
50
VHT icon
425
Vanguard Health Care ETF
VHT
$19B
$4K ﹤0.01%
25

Similar funds

AlphaMark Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, AlphaMark Advisors held 548 positions worth $236M, up 13% from $208M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

AlphaMark Advisors's Q1 2019 filing shows 49 new, 102 increased, 91 reduced and 33 closed positions. Its largest new stake was Celgene Corp: 46,814 shares worth $4.42M. The largest sale was Amgen, an estimated $4.41M.

By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 36% a quarter earlier, followed by Technology and Financials.

  • AlphaMark Advisors's largest Q1 2019 buy was Celgene Corp: 46,814 shares worth $4.42M.
  • AlphaMark Advisors added most to iShares Russell 2000 Value ETF in Q1 2019, an estimated $3.99M increase.
  • AlphaMark Advisors's biggest Q1 2019 reduction was Amgen, cutting an estimated $4.41M.
  • AlphaMark Advisors fully exited Motorcar Parts of America in Q1 2019, selling an estimated $826K.
  • AlphaMark Advisors's ten largest holdings make up 32% of its $236M portfolio in Q1 2019.
  • AlphaMark Advisors opened 49 new positions and closed 33 in Q1 2019.
  • AlphaMark Advisors's portfolio value rose 13% quarter-over-quarter to $236M.

Based on AlphaMark Advisors's 13F filing for Q1 2019, filed 9 May 2019.